Everardo Delforge Saad (Everardo Saad, Everardo D Saad)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Locally Advanced

Early Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical trials (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Everardo Delforge Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas, Leandro Garcia-Barrado, Tomasz Burzykowski, Marc Buyse
Trial Design for Cancer Immunotherapy: A Methodological Toolkit. Cancers 15 (18) (2023)
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, Marc E Buyse, Charles E Geyer, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Pierre Squifflet, Everardo Delforge Saad, Dominik Heinzmann, Carsten Denkert, Priya Rastogi, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Pierre Squifflet, Everardo Delforge Saad, Sibylle Loibl, Marion T van Mackelenbergh, Michael Untch, Priya Rastogi, Luca Gianni, Andreas Schneeweiß, PierFranco Conte, Martine J Piccart, Hervé R Bonnefoi, Christian Jackisch, Valentina Nekljudova, Gong Tang, Pinuccia Valagussa, Colin Neate, Richard D Gelber, Coralie Poncet, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David A Cameron, Gustavo Ismael, Norman Wolmark, Patricia Cortazar, Marc E Buyse, null null
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mickaël De Backer, Manju Sengar, Vikram Mathews, Samuel Salvaggio, Vaiva Deltuvaite-Thomas, Jean-Christophe Chiêm, Everardo Delforge Saad, Marc E Buyse
Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen. Clinical trials (London, England) (2023)
Marc E Buyse, Everardo Delforge Saad, Tomasz Burzykowski, Meredith M Regan, Christopher S Sweeney
Surrogacy Beyond Prognosis: The Importance of "Trial-Level" Surrogacy. The oncologist 27 (4) (2022)
Rita Saude Conde, Giacomo Bregni, Everardo Delforge Saad, Alain Hendlisz, Francesco Sclafani
JCOG0603: Are We Really Sure This Was a Negative Trial? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (7) (2022)
Everardo Delforge Saad, Marc Buyse
Commentary on Bamat et al. Clinical trials (London, England) 17 (5) (2020)
Everardo Delforge Saad, Marc Buyse
Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer. Cancers 12 (11) (2020)